Market Place
Sourcing Support
Centogene Announces Voting Results of Extraordinary General Meeting
04 Dec 2024 //
GLOBENEWSWIRE
Centogene Signs Strategic Transaction With Private Equity Group
13 Nov 2024 //
GLOBENEWSWIRE
Centogene Data On Novel Genetic Risk Factor For Parkinson`s
25 Sep 2024 //
GLOBENEWSWIRE
Centogene Receives Delisting Notice From Nasdaq
07 Aug 2024 //
GLOBENEWSWIRE
CENTOGENE Study Links 15% Of Parkinson`s Cases To Genetic Factors
01 Aug 2024 //
GLOBENEWSWIRE
C-Path And CENTOGENE MOU To Enhance Collaboration In Lysosomal Disease Research
20 Jun 2024 //
GLOBENEWSWIRE
CENTOGENE Resolutions Adopted At 2024 Annual General Meeting
31 May 2024 //
GLOBENEWSWIRE
Centogene and Evotec discover promising new molecule to treat Gaucher disease
16 May 2024 //
PHARMABIZ
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
15 May 2024 //
GLOBENEWSWIRE
CENTOGENE Reports Full Year 2023 Financial Results
15 May 2024 //
GLOBENEWSWIRE
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
14 May 2024 //
GLOBENEWSWIRE
Centogene and Evotec Discover New Potential Treatment for Gaucher Disease
14 May 2024 //
CONTRACT PHARMA
CENTOGENE Biodata From Over 850K Diverse Patients
10 May 2024 //
GLOBENEWSWIRE
CENTOGENE Receives Nasdaq Non-Compliance Notice
02 Apr 2024 //
GLOBENEWSWIRE
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing
19 Mar 2024 //
GLOBENEWSWIRE
CENTOGENE Explores Strategic Alternatives
28 Feb 2024 //
GLOBENEWSWIRE
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting
28 Feb 2024 //
GLOBENEWSWIRE
CENTOGENE Receives French Research Tax Credit Accreditation
24 Jan 2024 //
GLOBENEWSWIRE
CENTOGENE and The Michael J. Fox Foundation Announce Research Project
23 Jan 2024 //
GLOBENEWSWIRE
CENTOGENE Announces Preliminary Full Year 2023 Revenue
18 Jan 2024 //
GLOBENEWSWIRE
CENTOGENE Announces Voting Results of Extraordinary General Meeting
19 Dec 2023 //
GLOBENEWSWIRE
CENTOGENE™s FTD Genetic Study, EFRONT, Reaches Patient Enrollment Milestone
13 Dec 2023 //
GLOBENEWSWIRE
CENTOGENE Expands Multiomic Diagnostic Portfolio With Transcriptomic Offering
10 Oct 2023 //
GLOBENEWSWIRE
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
11 Sep 2023 //
GLOBENEWSWIRE
CENTOGENE Reports First Half 2023 Financial Results
07 Sep 2023 //
GLOBENEWSWIRE
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker
01 Sep 2023 //
GLOBENEWSWIRE
CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market
31 Aug 2023 //
GLOBENEWSWIRE
CENTOGENE to Participate in Upcoming Conferences in August
07 Aug 2023 //
GLOBENEWSWIRE
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
14 Jul 2023 //
GLOBENEWSWIRE
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World`s Largest Niemann-Pick Type C1 Disease Cohort
12 Jul 2023 //
GLOBENEWSWIRE
Lifera & CENTOGENE, Enter Strategic Collab - Forming Saudi Arabian Joint Venture
02 Jul 2023 //
PR NEWSWIRE
CENTOGENE Announces Approval of All Resolutions Tabled at 2023 General Meeting
30 Jun 2023 //
GLOBENEWSWIRE
CENTOGENE & Lifera, a Biopharma Company Owned by the PIF, Enter Collaboration
27 Jun 2023 //
GLOBENEWSWIRE
CENTOGENE Receives Notification Regarding Minimum Value of Shares Deficiency
14 Jun 2023 //
GLOBENEWSWIRE
CENTOGENE Reports Full Year 2022 Financial Results
16 May 2023 //
GLOBENEWSWIRE
CENTOGENE to Participate in Upcoming Conferences in May
05 May 2023 //
GLOBENEWSWIRE
CENTOGENE Accelerates Global Genetic Data Interpretation
26 Apr 2023 //
GLOBENEWSWIRE
Centogene to Participate in Upcoming Conferences in April
14 Apr 2023 //
GLOBENEWSWIRE
CENTOGENE Launches NEW CentoGenome
12 Apr 2023 //
GLOBENEWSWIRE
Centogene Extends Partnership With Takeda for Providing Access to Genetic Testing
11 Apr 2023 //
GLOBENEWSWIRE
CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer and General Manager
09 Mar 2023 //
GLOBENEWSWIRE
CENTOGENE to Participate in Upcoming Conferences in March
08 Mar 2023 //
GLOBENEWSWIRE
CENTOGENE Expands Study to Advance the Genetic Understanding of FTD
21 Feb 2023 //
GLOBENEWSWIRE
Centogene Regains Compliance With Nasdaq Listing Requirements
07 Feb 2023 //
GLOBENEWSWIRE
CENTOGENE to Participate in Conferences in Feb in Lead Up to Rare Disease Day
07 Feb 2023 //
GLOBENEWSWIRE
Premier and CENTOGENE Launch Partnership for De-Risk Rare Disease Development
09 Jan 2023 //
PR NEWSWIRE
CENTOGENE and Denali Extend Observational Study on Parkinson`s Disease Genetics
09 Jan 2023 //
GLOBENEWSWIRE
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
22 Dec 2022 //
GLOBENEWSWIRE
CENTOGENE Receives Nasdaq Non-Compliance Notice
16 Dec 2022 //
GLOBENEWSWIRE
CENTOGENE Announces Changes to Supervisory Board
21 Nov 2022 //
GLOBENEWSWIRE
CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
02 Nov 2022 //
GLOBENEWSWIRE
CENTOGENE to Participate in Upcoming Partnering Conferences in October
06 Oct 2022 //
GLOBENEWSWIRE
CENTOGENE Reaches12,500 Patient Milestone in World’s Largest Observational Study
03 Oct 2022 //
GLOBENEWSWIRE
CENTOGENE to Present at Upcoming Investor & Partnering Conferences in September
01 Sep 2022 //
GLOBENEWSWIRE
CENTOGENE Reports First Quarter 2022 Financial Results
15 Jul 2022 //
GLOBENEWSWIRE
CENTOGENE Announces Shareholder Approval of All Resolutions at 2022 AGM
27 Jun 2022 //
GLOBENEWSWIRE
CENTOGENE Announces Appointment of Miguel Coego Rios as Chief Financial Officer
27 Jun 2022 //
GLOBENEWSWIRE
CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND
13 Jun 2022 //
GLOBENEWSWIRE
